NOVEL CLEAVAGE PRODUCTS OF THE 3RD COMPONENT OF HUMAN-COMPLEMENT

被引:40
作者
HARRISON, RA
LACHMANN, PJ
机构
[1] UNIV LONDON IMPERIAL COLL SCI & TECHNOL,DEPT BIOCHEM,LONDON SW7 2AZ,ENGLAND
[2] MRC,MOLEC BIOL LAB,MECHANISMS TUMOUR IMMUNOL GRP,CAMBRIDGE CB2 2QH,ENGLAND
关键词
D O I
10.1016/0161-5890(80)90074-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:219 / 228
页数:10
相关论文
共 31 条
[1]  
BALLOW M, 1969, J IMMUNOL, V103, P944
[2]  
COOPER NR, 1975, J EXP MED, V141, P890
[3]  
Cuatrecasas P., 1971, METHOD ENZYMOL, V22, P345
[4]  
DASILVA WD, 1967, J EXP MED, V116, P1027
[5]  
FEARON DT, 1975, J IMMUNOL, V115, P1357
[6]   ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY DUE TO RESISTANCE OF ZYMOSAN-BOUND AMPLIFICATION CONVERTASE TO ENDOGENOUS REGULATORY MECHANISMS [J].
FEARON, DT ;
AUSTEN, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (04) :1683-1687
[7]   ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY WITH RABBIT ERYTHROCYTES BY CIRCUMVENTION OF REGULATORY ACTION OF ENDOGENOUS CONTROL PROTEINS [J].
FEARON, DT ;
AUSTEN, KF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (01) :22-33
[8]  
GHEBREHIWET B, 1978, J IMMUNOL, V120, P1774
[9]   MECHANISM OF ACTION OF C3B INACTIVATOR (CONGLUTINOGEN-ACTIVATING FACTOR) ON ITS NATURALLY OCCURRING SUBSTRATE, MAJOR FRAGMENT OF THIRD COMPONENT OF COMPLEMENT (C3B) [J].
GITLIN, JD ;
ROSEN, FS ;
LACHMANN, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 141 (05) :1221-1226
[10]   IMPROVED PURIFICATION PROCEDURE FOR THE 3RD COMPONENT OF COMPLEMENT AND BETA-1H GLOBULIN FROM HUMAN-SERUM [J].
HARRISON, RA ;
LACHMANN, PJ .
MOLECULAR IMMUNOLOGY, 1979, 16 (10) :767-776